Cargando…

Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner

Apigenin (APG) is an edible plant-derived flavonoid that shows modest antitumor activities in vitro and in vivo. APG treatment results in cell growth arrest and apoptosis in various types of tumors by modulating several signaling pathways. In the present study, we evaluated interactions between APG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Minghui, Wang, Xueshi, Zha, Daolong, Cai, Fangfang, Zhang, Wenjing, He, Yan, Huang, Qilai, Zhuang, Hongqin, Hua, Zi-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067669/ https://www.ncbi.nlm.nih.gov/pubmed/27752089 http://dx.doi.org/10.1038/srep35468

Ejemplares similares

Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-κB pathway
por: Chen, Minghui, et al.
Publicado: (2017)

Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer
por: Cai, Fangfang, et al.
Publicado: (2017)

Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
por: Kim, Jung Lim, et al.
Publicado: (2019)

Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner
por: Jiang, Weiwei, et al.
Publicado: (2020)

Non-Thermal Plasma Couples Oxidative Stress to TRAIL Sensitization through DR5 Upregulation
por: Hwang, Soon Young, et al.
Publicado: (2020)

Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53
por: Zhou, Xinyu, et al.
Publicado: (2020)

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5
por: van Geelen, Caroline MM, et al.
Publicado: (2011)

Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
por: Meijer, A, et al.
Publicado: (2013)

FADD is a key regulator of lipid metabolism
por: Zhuang, Hongqin, et al.
Publicado: (2016)

Combination of TRAIL with Bortezomib Shifted Apoptotic Signaling from DR4 to DR5 Death Receptor by Selective Internalization and Degradation of DR4
por: Bychkov, Maxim L., et al.
Publicado: (2014)

AK2 Promotes the Migration and Invasion of Lung Adenocarcinoma by Activating TGF-β/Smad Pathway In vitro and In vivo
por: Cai, Fangfang, et al.
Publicado: (2021)

c-Jun NH(2)-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL
por: Fu, Lei, et al.
Publicado: (2010)

MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation
por: Lim, Sung-Chul, et al.
Publicado: (2017)

Citrus-derived DHCP inhibits mitochondrial complex II to enhance TRAIL sensitivity via ROS-induced DR5 upregulation
por: Chen, Lei, et al.
Publicado: (2021)

3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
por: Chen, Yuzhong, et al.
Publicado: (2018)

Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells
por: Woo, Seon Min, et al.
Publicado: (2020)

Downregulation of c-FLIP and upregulation of DR-5 by cantharidin sensitizes TRAIL-mediated apoptosis in prostate cancer cells via autophagy flux
por: Nazim, Uddin Md, et al.
Publicado: (2020)

3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
por: Chen, Yuzhong, et al.
Publicado: (2022)

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation
por: Qiao, Chunxia, et al.
Publicado: (2012)

Targeting AML through DR4 with a novel variant of rhTRAIL
por: Szegezdi, Eva, et al.
Publicado: (2011)

Activation of TRAIL‐DR5 pathway promotes sensorineural degeneration in the inner ear
por: Kao, Shyan‐Yuan, et al.
Publicado: (2016)

Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
por: Chen, Shuzhen, et al.
Publicado: (2010)

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
por: Artykov, Artem A., et al.
Publicado: (2021)

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells
por: Choi, Eunah, et al.
Publicado: (2006)

Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation
por: Chen, Lei, et al.
Publicado: (2016)

Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells
por: Yabe, Michihiro, et al.
Publicado: (2018)

BIX-01294 sensitizes renal cancer Caki cells to TRAIL-induced apoptosis through downregulation of survivin expression and upregulation of DR5 expression
por: Woo, Seon Min, et al.
Publicado: (2018)

Maritoclax Enhances TRAIL-Induced Apoptosis via CHOP-Mediated Upregulation of DR5 and miR-708-Mediated Downregulation of cFLIP
por: Jeon, Mi-Yeon, et al.
Publicado: (2018)

Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4
por: Obaidi, Ismael, et al.
Publicado: (2020)

Apigenin Sensitizes Huh-7 Human Hepatocellular Carcinoma Cells to TRAIL-induced Apoptosis
por: Kim, Eun Young, et al.
Publicado: (2012)

DrGA: cancer driver gene analysis in a simpler manner
por: Nguyen, Quang-Huy, et al.
Publicado: (2022)

TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Aβ
por: Fossati, S, et al.
Publicado: (2012)

Corrigendum: Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
por: Artykov, Artem A., et al.
Publicado: (2022)

Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients
por: Wu, Yanqiu, et al.
Publicado: (2015)

TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA
por: Han, Han, et al.
Publicado: (2017)

Potentiation of TRAIL-Induced Apoptosis in TRAIL-Resistant Cholangiocarcinoma Cells by Curcumin through the Induction of DR5 Membrane Localization and Disruption of the Anti-Apoptotic Complex DR5/DDX3/GSK3β
por: Visitnonthachai, Daranee, et al.
Publicado: (2023)

Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy
por: Qiu, Fan, et al.
Publicado: (2013)

Depletion of CABYR-a/b sensitizes lung cancer cells to TRAIL-induced apoptosis through YAP/p73-mediated DR5 upregulation
por: Xiao, Qianqian, et al.
Publicado: (2016)

Dexamethasone Inhibits TRAIL-Induced Apoptosis through c-FLIP(L) Upregulation and DR5 Downregulation by GSK3β Activation in Cancer Cells
por: Jeon, Mi-Yeon, et al.
Publicado: (2020)

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma
por: Yagolovich, Anne V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6j1bq5j2er0jeqnt47s85v96na